Janney Says Bluebird's Therapies Are 'Encouraging,' But Stock Is Fairly Valued
March 14, 2018 at 09:53 AM EDT
Bluebird bio Inc (NASDAQ: BLUE), a clinical-stage biotechnology company that focuses on therapies for the treatment of severe diseases ...